CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash Flows From Operating Activities
Net (loss) income	$ (287.8)	$ 879.4	$ (863.6)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization, including impairments of finite-lived intangible assets	2,627.5	1,737.6	2,015.8
Amortization and write-off of debt discounts and debt issuance costs	145.3	70.0	89.5
In-process research and development impairments	144.5	21.0	151.9
Acquisition accounting adjustment on inventory sold	133.7	27.3	372.4
Acquisition-related contingent consideration	(23.0)	(14.1)	(29.2)
Allowances for losses on accounts receivable and inventories	115.3	81.3	68.3
Deferred income taxes	(7.0)	75.6	(515.9)
Loss (gain) on disposal of assets and businesses	5.4	(253.5)	10.2
Additions (reduction) to accrued legal settlements	37.3	(44.7)	220.5
Payments of accrued legal settlements	(32.9)	(3.2)	(180.8)
Share-based compensation	140.1	78.2	45.5
Tax benefits from share-based compensation	(56.8)	(17.1)	(24.2)
Foreign exchange loss	95.2	135.1	9.8
Loss on extinguishment of debt	20.0	129.6	65.0
Payment of accreted interest on contingent consideration	(23.0)	(10.7)	(11.1)
Other	(11.2)	32.3	(3.8)
Changes in operating assets and liabilities:
Trade receivables	(625.9)	(572.4)	(300.6)
Inventories	(276.0)	(192.8)	(122.7)
Prepaid expenses and other current assets	(90.6)	(110.3)	121.5
Accounts payable, accrued and other liabilities	170.3	246.1	(76.5)
Net cash provided by operating activities	2,200.4	2,294.7	1,042.0
Cash Flows From Investing Activities
Acquisition of businesses, net of cash acquired	(15,457.4)	(1,102.6)	(5,253.5)
Acquisition of intangible assets and other assets	(68.1)	(179.0)	(69.6)
Purchases of property, plant and equipment	(235.2)	(291.6)	(115.3)
Increase in restricted cash	66.7	53.2	35.2
Net settlement of assumed derivative contracts	184.6	0.0	0.0
Settlement of foreign currency forward exchange contracts	(26.3)	0.0	0.0
Purchases of marketable securities	(49.3)	(72.0)	(18.2)
Purchase of equity method investment	0.0	(75.9)	0.0
Proceeds from sale of equity method investment	0.0	75.9	0.0
Proceeds from sale of assets and businesses, net of costs to sell	12.8	1,492.3	41.1
Increase in restricted cash	(5.2)	0.0	0.0
Net cash used in investing activities	(15,577.4)	(99.7)	(5,380.3)
Cash Flows From Financing Activities
Issuance of long-term debt, net of discount	17,817.4	1,629.6	8,385.4
Repayments of long-term debt	(2,055.1)	(3,888.0)	(6,326.2)
Short-term debt borrowings	7.6	19.4	27.4
Repayments of convertible notes assumed	(7.9)	(28.4)	(75.1)
Repayments of convertible notes assumed	(3,122.8)	0.0	0.0
Issuance of common stock, net	1,432.8	0.0	2,307.4
Repurchases of common shares	(72.4)	0.0	(55.6)
Proceeds from exercise of stock options	30.2	17.2	10.0
Excess tax benefits from share-based compensation	56.8	17.1	24.2
Payments of employee withholding tax upon vesting of share-based awards	(88.0)	(44.1)	(65.5)
Payments of contingent consideration	(150.9)	(106.1)	(130.1)
Payments of deferred consideration	(54.7)	0.0	0.0
Payments of financing costs	(102.9)	(52.2)	(72.1)
Other	(8.3)	(8.2)	(2.1)
Net cash provided by (used in) financing activities	13,681.8	(2,443.7)	4,027.7
Effect of exchange rate changes on cash and cash equivalents	(30.1)	(29.0)	(5.2)
Net increase (decrease) in cash and cash equivalents	274.7	(277.7)	(315.8)
Cash and cash equivalents, beginning of year	322.6	600.3	916.1
Cash and cash equivalents, end of year	597.3	322.6	600.3
Non-Cash Investing and Financing Activities
Acquisition of businesses, contingent and deferred consideration obligations at fair value	(1,695.8)	(132.6)	(76.1)
Acquisition of businesses, debt assumed	$ (3,129.2)	$ (11.2)	$ (4,264.7)